This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hamlyn, J. M. Articles by Ludens, J. H. Search for Related Content PubMed PubMed Citation Articles by Hamlyn, J. M. Articles by Ludens, J. H.

Hypertension, Vol 13, 681-689, Copyright © 1989 by American Heart Association

ARTICLES

Isolation and characterization of a sodium pump inhibitor from human plasma

JM Hamlyn, DW Harris, MA Clark, AC Rogowski, RJ White and JH Ludens
Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland 21201.

An endogenous sodium pump inhibitor has been purified from human plasma. The purification scheme involved large scale dialysis, extraction of lyophilized dialysate by methanol followed by preparative and semipreparative scale reverse-phase high-performance chromatography. A single peak of biologically active material was obtained enriched by a factor of greater than 10 billion. This material showed high chromatographic polarity, was inactivated by charring, strong acid, or alkali, and was resistant to short-term boiling. The purified material had a molecular weight between 300 and 900 g/mol and was insensitive to type I esterase and a variety of proteolytic enzymes. The purified factor inhibited the ouabain-sensitive uptake of 86Rb by human erythrocytes, binding of [3H]ouabain, and activity of dog kidney Na,K-adenosine triphosphatase (ATPase) with high affinity (less than 0.3 nM) in a time- and dose-dependent manner. Maximally effective concentrations of the digitalislike factor showed no effect on either human red blood cell Mg- or Ca-ATPase, rabbit muscle sarcoplasmic reticulum Ca-ATPase, or guinea pig stomach H,K-ATPase. The purified material is a highly potent selective inhibitor of the ion transport, receptor, and hydrolytic functions of the sodium pump. The characteristic properties of this substance suggest it may be a mammalian endogenous digitalis and may be similar to the sodium transport inhibitor detected in the plasma of volume-sensitive forms of experimental and human hypertension.

This article has been cited by other articles:

				N. Mahon and W.J. Mckenna Digoxin-like immunoreactive substances in hypertrophic cardiomyopathy Eur. Heart J., July 1, 2000; 21(13): 1034 - 1036. [PDF]

				B. S. Huang and F. H. H. Leenen Brain `Ouabain,' Sodium, and Arterial Baroreflex in Spontaneously Hypertensive Rats Hypertension, April 1, 1995; 25(4): 814 - 817. [Abstract] [Full Text]